SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3o96'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1HK3_A_T44A3004_1 (SERUM ALBUMIN)	3o96	RAC-ALPHA SERINE/THREONINE-PRO TEIN KINASE (Homo sapiens)	4 / 7	GLU A 256 VAL A 338 MET A 339 LEU A 239	GLU A 256 ( 0.6A) VAL A 338 ( 0.6A) MET A 339 ( 0.0A) LEU A 239 ( 0.6A)	0.83A	1hk3A-3o96A: 1.6	1hk3A-3o96A: 21.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RJD_A_SAMA801_1 (CARBOXY METHYL TRANSFERASE FOR PROTEIN PHOSPHATASE 2A CATALYTIC SUBUNIT)	3o96	RAC-ALPHA SERINE/THREONINE-PRO TEIN KINASE (Homo sapiens)	4 / 6	ASP A 331 TYR A 272 ASN A 279 GLU A 319	ASP A 331 ( 0.6A) TYR A 272 (-1.3A) ASN A 279 ( 0.6A) GLU A 319 ( 0.5A)	1.28A	1rjdA-3o96A: undetectable	1rjdA-3o96A: 21.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RJD_B_SAMB802_1 (CARBOXY METHYL TRANSFERASE FOR PROTEIN PHOSPHATASE 2A CATALYTIC SUBUNIT)	3o96	RAC-ALPHA SERINE/THREONINE-PRO TEIN KINASE (Homo sapiens)	4 / 6	ASP A 331 TYR A 272 ASN A 279 GLU A 319	ASP A 331 ( 0.6A) TYR A 272 (-1.3A) ASN A 279 ( 0.6A) GLU A 319 ( 0.5A)	1.28A	1rjdB-3o96A: undetectable	1rjdB-3o96A: 21.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RJD_C_SAMC803_1 (CARBOXY METHYL TRANSFERASE FOR PROTEIN PHOSPHATASE 2A CATALYTIC SUBUNIT)	3o96	RAC-ALPHA SERINE/THREONINE-PRO TEIN KINASE (Homo sapiens)	4 / 6	ASP A 331 TYR A 272 ASN A 279 GLU A 319	ASP A 331 ( 0.6A) TYR A 272 (-1.3A) ASN A 279 ( 0.6A) GLU A 319 ( 0.5A)	1.28A	1rjdC-3o96A: undetectable	1rjdC-3o96A: 21.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XF1_A_ACTA1107_0 (C5A PEPTIDASE)	3o96	RAC-ALPHA SERINE/THREONINE-PRO TEIN KINASE (Homo sapiens)	4 / 5	LEU A 282 GLY A 286 HIS A 287 ILE A 288	LEU A 282 ( 0.6A) GLY A 286 ( 0.0A) HIS A 287 ( 1.0A) ILE A 288 ( 0.7A)	0.92A	1xf1A-3o96A: undetectable	1xf1A-3o96A: 21.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIK_J_CHDJ60_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 1)	3o96	RAC-ALPHA SERINE/THREONINE-PRO TEIN KINASE (Homo sapiens)	4 / 7	LEU A 379 PHE A 407 ARG A 249 MET A 343	LEU A 379 ( 0.6A) PHE A 407 ( 1.3A) ARG A 249 ( 0.6A) MET A 343 ( 0.0A)	1.01A	2eikA-3o96A: 0.5 2eikJ-3o96A: undetectable	2eikA-3o96A: 19.89 2eikJ-3o96A: 9.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FUM_A_MIXA539_1 (PROBABLE SERINE/THREONINE-PRO TEIN KINASE PKNB)	3o96	RAC-ALPHA SERINE/THREONINE-PRO TEIN KINASE (Homo sapiens)	7 / 12	LEU A 156 VAL A 164 ALA A 177 ASP A 274 LYS A 276 ASN A 279 MET A 281	LEU A 156 ( 0.6A) VAL A 164 ( 0.6A) ALA A 177 ( 0.0A) ASP A 274 ( 0.5A) LYS A 276 ( 0.0A) ASN A 279 ( 0.6A) MET A 281 ( 0.0A)	0.83A	2fumA-3o96A: 24.2	2fumA-3o96A: 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FUM_C_MIXC2539_1 (PROBABLE SERINE/THREONINE-PRO TEIN KINASE PKNB)	3o96	RAC-ALPHA SERINE/THREONINE-PRO TEIN KINASE (Homo sapiens)	6 / 12	LEU A 156 GLY A 157 VAL A 164 ALA A 177 MET A 227 TYR A 229	LEU A 156 ( 0.6A) GLY A 157 ( 0.0A) VAL A 164 ( 0.6A) ALA A 177 ( 0.0A) MET A 227 ( 0.0A) TYR A 229 ( 1.3A)	0.71A	2fumC-3o96A: 24.2	2fumC-3o96A: 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FUM_D_MIXD3539_1 (PROBABLE SERINE/THREONINE-PRO TEIN KINASE PKNB)	3o96	RAC-ALPHA SERINE/THREONINE-PRO TEIN KINASE (Homo sapiens)	7 / 12	LEU A 156 VAL A 164 ALA A 177 MET A 227 LYS A 276 ASN A 279 MET A 281	LEU A 156 ( 0.6A) VAL A 164 ( 0.6A) ALA A 177 ( 0.0A) MET A 227 ( 0.0A) LYS A 276 ( 0.0A) ASN A 279 ( 0.6A) MET A 281 ( 0.0A)	0.92A	2fumD-3o96A: 24.0	2fumD-3o96A: 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2J2P_D_SC2D1290_1 (FICOLIN-2)	3o96	RAC-ALPHA SERINE/THREONINE-PRO TEIN KINASE (Homo sapiens)	4 / 5	TRP A 332 TRP A 333 ARG A 391 LEU A 383	TRP A 332 ( 0.5A) TRP A 333 ( 0.5A) ARG A 391 ( 0.6A) LEU A 383 ( 0.6A)	1.48A	2j2pD-3o96A: undetectable 2j2pF-3o96A: undetectable	2j2pD-3o96A: 19.05 2j2pF-3o96A: 19.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZXW_W_CHDW1060_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 1)	3o96	RAC-ALPHA SERINE/THREONINE-PRO TEIN KINASE (Homo sapiens)	4 / 7	LEU A 379 PHE A 407 ARG A 249 MET A 343	LEU A 379 ( 0.6A) PHE A 407 ( 1.3A) ARG A 249 ( 0.6A) MET A 343 ( 0.0A)	1.01A	2zxwN-3o96A: undetectable 2zxwW-3o96A: undetectable	2zxwN-3o96A: 19.89 2zxwW-3o96A: 9.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG4_W_CHDW1059_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 1)	3o96	RAC-ALPHA SERINE/THREONINE-PRO TEIN KINASE (Homo sapiens)	4 / 7	LEU A 379 PHE A 407 ARG A 249 MET A 343	LEU A 379 ( 0.6A) PHE A 407 ( 1.3A) ARG A 249 ( 0.6A) MET A 343 ( 0.0A)	1.04A	3ag4N-3o96A: 1.0 3ag4W-3o96A: undetectable	3ag4N-3o96A: 19.89 3ag4W-3o96A: 9.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IJD_A_C2FA314_0 (UNCHARACTERIZED PROTEIN)	3o96	RAC-ALPHA SERINE/THREONINE-PRO TEIN KINASE (Homo sapiens)	5 / 12	LEU A 316 VAL A 337 GLY A 336 LEU A 380 ILE A 257	LEU A 316 ( 0.6A) VAL A 337 ( 0.6A) GLY A 336 ( 0.0A) LEU A 380 ( 0.6A) ILE A 257 ( 0.7A)	1.11A	3ijdA-3o96A: undetectable	3ijdA-3o96A: 22.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3V5W_A_8PRA701_1 (G-PROTEIN COUPLED RECEPTOR KINASE 2)	3o96	RAC-ALPHA SERINE/THREONINE-PRO TEIN KINASE (Homo sapiens)	6 / 12	GLY A 159 GLY A 162 VAL A 164 ALA A 177 LYS A 179 LEU A 181	GLY A 159 ( 0.0A) GLY A 162 ( 0.0A) VAL A 164 ( 0.6A) ALA A 177 ( 0.0A) LYS A 179 ( 0.0A) LEU A 181 ( 0.6A)	0.58A	3v5wA-3o96A: 29.3	3v5wA-3o96A: 25.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	3o96	RAC-ALPHA SERINE/THREONINE-PRO TEIN KINASE (Homo sapiens)	4 / 5	ILE A 6 VAL A 106 LEU A 110 ASP A 32	ILE A 6 ( 0.4A) VAL A 106 ( 0.6A) LEU A 110 ( 0.6A) ASP A 32 ( 0.6A)	0.88A	3wzdA-3o96A: 19.5	3wzdA-3o96A: 23.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CKJ_A_ADNA2014_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET)	3o96	RAC-ALPHA SERINE/THREONINE-PRO TEIN KINASE (Homo sapiens)	6 / 10	LEU A 156 GLY A 157 GLY A 159 VAL A 164 ALA A 177 TYR A 229	LEU A 156 ( 0.6A) GLY A 157 ( 0.0A) GLY A 159 ( 0.0A) VAL A 164 ( 0.6A) ALA A 177 ( 0.0A) TYR A 229 ( 1.3A)	0.53A	4ckjA-3o96A: 20.1	4ckjA-3o96A: 23.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4L9I_A_8PRA601_1 (RHODOPSIN KINASE)	3o96	RAC-ALPHA SERINE/THREONINE-PRO TEIN KINASE (Homo sapiens)	4 / 7	VAL A 164 ALA A 177 LEU A 181 MET A 227	VAL A 164 ( 0.6A) ALA A 177 ( 0.0A) LEU A 181 ( 0.6A) MET A 227 ( 0.0A)	0.28A	4l9iA-3o96A: 9.2	4l9iA-3o96A: 29.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O8Z_A_BBIA402_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	3o96	RAC-ALPHA SERINE/THREONINE-PRO TEIN KINASE (Homo sapiens)	4 / 5	PHE A 408 PHE A 407 LEU A 384 PRO A 348	PHE A 408 ( 1.3A) PHE A 407 ( 1.3A) LEU A 384 ( 0.6A) PRO A 348 ( 1.1A)	1.23A	4o8zA-3o96A: undetectable	4o8zA-3o96A: 21.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QTU_D_SAMD301_1 (PUTATIVE METHYLTRANSFERASE BUD23)	3o96	RAC-ALPHA SERINE/THREONINE-PRO TEIN KINASE (Homo sapiens)	4 / 5	LEU A 202 SER A 205 ASP A 292 ASP A 274	LEU A 202 ( 0.6A) SER A 205 (-0.0A) ASP A 292 (-0.6A) ASP A 274 ( 0.5A)	1.34A	4qtuD-3o96A: undetectable	4qtuD-3o96A: 18.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ZDZ_A_TPFA602_1 (LANOSTEROL 14-ALPHA DEMETHYLASE)	3o96	RAC-ALPHA SERINE/THREONINE-PRO TEIN KINASE (Homo sapiens)	4 / 7	PHE A 408 ILE A 402 GLY A 254 MET A 343	PHE A 408 ( 1.3A) ILE A 402 ( 0.4A) GLY A 254 ( 0.0A) MET A 343 ( 0.0A)	0.93A	4zdzA-3o96A: undetectable	4zdzA-3o96A: 21.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ESJ_A_TPFA602_1 (LANOSTEROL 14-ALPHA DEMETHYLASE)	3o96	RAC-ALPHA SERINE/THREONINE-PRO TEIN KINASE (Homo sapiens)	4 / 8	PHE A 408 ILE A 402 GLY A 254 MET A 343	PHE A 408 ( 1.3A) ILE A 402 ( 0.4A) GLY A 254 ( 0.0A) MET A 343 ( 0.0A)	0.92A	5esjA-3o96A: undetectable	5esjA-3o96A: 21.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZF_E_AZ1E2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 6J9-ZEU-DAR-ACA-DAR- NH2)	3o96	RAC-ALPHA SERINE/THREONINE-PRO TEIN KINASE (Homo sapiens)	4 / 7	GLY A 157 GLY A 159 LYS A 179 LEU A 181	GLY A 157 ( 0.0A) GLY A 159 ( 0.0A) LYS A 179 ( 0.0A) LEU A 181 ( 0.6A)	0.18A	5izfA-3o96A: 29.3	5izfA-3o96A: 34.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	3o96	RAC-ALPHA SERINE/THREONINE-PRO TEIN KINASE (Homo sapiens)	5 / 7	GLY A 157 GLY A 159 GLY A 162 VAL A 164 LEU A 181	GLY A 157 ( 0.0A) GLY A 159 ( 0.0A) GLY A 162 ( 0.0A) VAL A 164 ( 0.6A) LEU A 181 ( 0.6A)	0.19A	5izjB-3o96A: 30.4	5izjB-3o96A: 34.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5IZJ_G_AZ1G2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR)	3o96	RAC-ALPHA SERINE/THREONINE-PRO TEIN KINASE (Homo sapiens)	5 / 7	GLY A 157 GLY A 159 VAL A 164 LYS A 179 LEU A 181	GLY A 157 ( 0.0A) GLY A 159 ( 0.0A) VAL A 164 ( 0.6A) LYS A 179 ( 0.0A) LEU A 181 ( 0.6A)	0.38A	5izjA-3o96A: 30.3	5izjA-3o96A: 34.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5J5X_B_AZ1B2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAL-DAR-DAR- DAR-DAR)	3o96	RAC-ALPHA SERINE/THREONINE-PRO TEIN KINASE (Homo sapiens)	4 / 7	GLY A 157 GLY A 159 VAL A 164 LYS A 179	GLY A 157 ( 0.0A) GLY A 159 ( 0.0A) VAL A 164 ( 0.6A) LYS A 179 ( 0.0A)	0.41A	5j5xA-3o96A: 29.5	5j5xA-3o96A: 34.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5MZJ_A_TEPA2401_1 (ADENOSINE RECEPTOR A2A,SOLUBLE CYTOCHROME B562,ADENOSINE RECEPTOR A2A)	3o96	RAC-ALPHA SERINE/THREONINE-PRO TEIN KINASE (Homo sapiens)	4 / 8	LEU A 335 GLU A 256 LEU A 280 ILE A 290	LEU A 335 ( 0.6A) GLU A 256 ( 0.6A) LEU A 280 ( 0.6A) ILE A 290 (-0.7A)	0.99A	5mzjA-3o96A: 2.3	5mzjA-3o96A: 20.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UUN_A_ACTA309_0 (GLUTATHIONE S-TRANSFERASE-LIKE PROTEIN)	3o96	RAC-ALPHA SERINE/THREONINE-PRO TEIN KINASE (Homo sapiens)	4 / 4	LEU A 392 GLY A 382 SER A 381 SER A 378	LEU A 392 ( 0.6A) GLY A 382 ( 0.0A) SER A 381 ( 0.0A) SER A 378 ( 0.0A)	1.28A	5uunA-3o96A: undetectable	5uunA-3o96A: 20.90

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1HK3_A_T44A3004_1","SERUM ALBUMIN","3o96","RAC-ALPHA SERINE\/THREONINE-PROTEIN KINASE","Homo sapiens",4,"GLU A 256;VAL A 338;MET A 339;LEU A 239","GLU A 256 ( 0.6A);VAL A 338 ( 0.6A);MET A 339 ( 0.0A);LEU A 239 ( 0.6A)","0.83A","1hk3A-3o96A:1.6","1hk3A-3o96A:21.63"],["1RJD_A_SAMA801_1","CARBOXY METHYL TRANSFERASE FOR PROTEIN PHOSPHATASE 2A CATALYTIC SUBUNIT","3o96","RAC-ALPHA SERINE\/THREONINE-PROTEIN KINASE","Homo sapiens",4,"ASP A 331;TYR A 272;ASN A 279;GLU A 319","ASP A 331 ( 0.6A);TYR A 272 (-1.3A);ASN A 279 ( 0.6A);GLU A 319 ( 0.5A)","1.28A","1rjdA-3o96A:undetectable","1rjdA-3o96A:21.96"],["1RJD_B_SAMB802_1","CARBOXY METHYL TRANSFERASE FOR PROTEIN PHOSPHATASE 2A CATALYTIC SUBUNIT","3o96","RAC-ALPHA SERINE\/THREONINE-PROTEIN KINASE","Homo sapiens",4,"ASP A 331;TYR A 272;ASN A 279;GLU A 319","ASP A 331 ( 0.6A);TYR A 272 (-1.3A);ASN A 279 ( 0.6A);GLU A 319 ( 0.5A)","1.28A","1rjdB-3o96A:undetectable","1rjdB-3o96A:21.96"],["1RJD_C_SAMC803_1","CARBOXY METHYL TRANSFERASE FOR PROTEIN PHOSPHATASE 2A CATALYTIC SUBUNIT","3o96","RAC-ALPHA SERINE\/THREONINE-PROTEIN KINASE","Homo sapiens",4,"ASP A 331;TYR A 272;ASN A 279;GLU A 319","ASP A 331 ( 0.6A);TYR A 272 (-1.3A);ASN A 279 ( 0.6A);GLU A 319 ( 0.5A)","1.28A","1rjdC-3o96A:undetectable","1rjdC-3o96A:21.96"],["1XF1_A_ACTA1107_0","C5A PEPTIDASE","3o96","RAC-ALPHA SERINE\/THREONINE-PROTEIN KINASE","Homo sapiens",4,"LEU A 282;GLY A 286;HIS A 287;ILE A 288","LEU A 282 ( 0.6A);GLY A 286 ( 0.0A);HIS A 287 ( 1.0A);ILE A 288 ( 0.7A)","0.92A","1xf1A-3o96A:undetectable","1xf1A-3o96A:21.05"],["2EIK_J_CHDJ60_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 1","3o96","RAC-ALPHA SERINE\/THREONINE-PROTEIN KINASE","Homo sapiens",4,"LEU A 379;PHE A 407;ARG A 249;MET A 343","LEU A 379 ( 0.6A);PHE A 407 ( 1.3A);ARG A 249 ( 0.6A);MET A 343 ( 0.0A)","1.01A","2eikA-3o96A:0.5;2eikJ-3o96A:undetectable","2eikA-3o96A:19.89;2eikJ-3o96A:9.90"],["2FUM_A_MIXA539_1","PROBABLE SERINE\/THREONINE-PROTEIN KINASE PKNB","3o96","RAC-ALPHA SERINE\/THREONINE-PROTEIN KINASE","Homo sapiens",7,"LEU A 156;VAL A 164;ALA A 177;ASP A 274;LYS A 276;ASN A 279;MET A 281","LEU A 156 ( 0.6A);VAL A 164 ( 0.6A);ALA A 177 ( 0.0A);ASP A 274 ( 0.5A);LYS A 276 ( 0.0A);ASN A 279 ( 0.6A);MET A 281 ( 0.0A)","0.83A","2fumA-3o96A:24.2","2fumA-3o96A:20.00"],["2FUM_C_MIXC2539_1","PROBABLE SERINE\/THREONINE-PROTEIN KINASE PKNB","3o96","RAC-ALPHA SERINE\/THREONINE-PROTEIN KINASE","Homo sapiens",6,"LEU A 156;GLY A 157;VAL A 164;ALA A 177;MET A 227;TYR A 229","LEU A 156 ( 0.6A);GLY A 157 ( 0.0A);VAL A 164 ( 0.6A);ALA A 177 ( 0.0A);MET A 227 ( 0.0A);TYR A 229 ( 1.3A)","0.71A","2fumC-3o96A:24.2","2fumC-3o96A:20.00"],["2FUM_D_MIXD3539_1","PROBABLE SERINE\/THREONINE-PROTEIN KINASE PKNB","3o96","RAC-ALPHA SERINE\/THREONINE-PROTEIN KINASE","Homo sapiens",7,"LEU A 156;VAL A 164;ALA A 177;MET A 227;LYS A 276;ASN A 279;MET A 281","LEU A 156 ( 0.6A);VAL A 164 ( 0.6A);ALA A 177 ( 0.0A);MET A 227 ( 0.0A);LYS A 276 ( 0.0A);ASN A 279 ( 0.6A);MET A 281 ( 0.0A)","0.92A","2fumD-3o96A:24.0","2fumD-3o96A:20.00"],["2J2P_D_SC2D1290_1","FICOLIN-2;FICOLIN-2","3o96","RAC-ALPHA SERINE\/THREONINE-PROTEIN KINASE","Homo sapiens",4,"TRP A 332;TRP A 333;ARG A 391;LEU A 383","TRP A 332 ( 0.5A);TRP A 333 ( 0.5A);ARG A 391 ( 0.6A);LEU A 383 ( 0.6A)","1.48A","2j2pD-3o96A:undetectable;2j2pF-3o96A:undetectable","2j2pD-3o96A:19.05;2j2pF-3o96A:19.05"],["2ZXW_W_CHDW1060_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 1","3o96","RAC-ALPHA SERINE\/THREONINE-PROTEIN KINASE","Homo sapiens",4,"LEU A 379;PHE A 407;ARG A 249;MET A 343","LEU A 379 ( 0.6A);PHE A 407 ( 1.3A);ARG A 249 ( 0.6A);MET A 343 ( 0.0A)","1.01A","2zxwN-3o96A:undetectable;2zxwW-3o96A:undetectable","2zxwN-3o96A:19.89;2zxwW-3o96A:9.90"],["3AG4_W_CHDW1059_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 1","3o96","RAC-ALPHA SERINE\/THREONINE-PROTEIN KINASE","Homo sapiens",4,"LEU A 379;PHE A 407;ARG A 249;MET A 343","LEU A 379 ( 0.6A);PHE A 407 ( 1.3A);ARG A 249 ( 0.6A);MET A 343 ( 0.0A)","1.04A","3ag4N-3o96A:1.0;3ag4W-3o96A:undetectable","3ag4N-3o96A:19.89;3ag4W-3o96A:9.90"],["3IJD_A_C2FA314_0","UNCHARACTERIZED PROTEIN","3o96","RAC-ALPHA SERINE\/THREONINE-PROTEIN KINASE","Homo sapiens",5,"LEU A 316;VAL A 337;GLY A 336;LEU A 380;ILE A 257","LEU A 316 ( 0.6A);VAL A 337 ( 0.6A);GLY A 336 ( 0.0A);LEU A 380 ( 0.6A);ILE A 257 ( 0.7A)","1.11A","3ijdA-3o96A:undetectable","3ijdA-3o96A:22.03"],["3V5W_A_8PRA701_1","G-PROTEIN COUPLED RECEPTOR KINASE 2","3o96","RAC-ALPHA SERINE\/THREONINE-PROTEIN KINASE","Homo sapiens",6,"GLY A 159;GLY A 162;VAL A 164;ALA A 177;LYS A 179;LEU A 181","GLY A 159 ( 0.0A);GLY A 162 ( 0.0A);VAL A 164 ( 0.6A);ALA A 177 ( 0.0A);LYS A 179 ( 0.0A);LEU A 181 ( 0.6A)","0.58A","3v5wA-3o96A:29.3","3v5wA-3o96A:25.76"],["3WZD_A_LEVA1201_2","VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2","3o96","RAC-ALPHA SERINE\/THREONINE-PROTEIN KINASE","Homo sapiens",4,"ILE A   6;VAL A 106;LEU A 110;ASP A  32","ILE A   6 ( 0.4A);VAL A 106 ( 0.6A);LEU A 110 ( 0.6A);ASP A  32 ( 0.6A)","0.88A","3wzdA-3o96A:19.5","3wzdA-3o96A:23.76"],["4CKJ_A_ADNA2014_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET","3o96","RAC-ALPHA SERINE\/THREONINE-PROTEIN KINASE","Homo sapiens",6,"LEU A 156;GLY A 157;GLY A 159;VAL A 164;ALA A 177;TYR A 229","LEU A 156 ( 0.6A);GLY A 157 ( 0.0A);GLY A 159 ( 0.0A);VAL A 164 ( 0.6A);ALA A 177 ( 0.0A);TYR A 229 ( 1.3A)","0.53A","4ckjA-3o96A:20.1","4ckjA-3o96A:23.42"],["4L9I_A_8PRA601_1","RHODOPSIN KINASE","3o96","RAC-ALPHA SERINE\/THREONINE-PROTEIN KINASE","Homo sapiens",4,"VAL A 164;ALA A 177;LEU A 181;MET A 227","VAL A 164 ( 0.6A);ALA A 177 ( 0.0A);LEU A 181 ( 0.6A);MET A 227 ( 0.0A)","0.28A","4l9iA-3o96A:9.2","4l9iA-3o96A:29.82"],["4O8Z_A_BBIA402_1","NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL","3o96","RAC-ALPHA SERINE\/THREONINE-PROTEIN KINASE","Homo sapiens",4,"PHE A 408;PHE A 407;LEU A 384;PRO A 348","PHE A 408 ( 1.3A);PHE A 407 ( 1.3A);LEU A 384 ( 0.6A);PRO A 348 ( 1.1A)","1.23A","4o8zA-3o96A:undetectable","4o8zA-3o96A:21.02"],["4QTU_D_SAMD301_1","PUTATIVE METHYLTRANSFERASE BUD23","3o96","RAC-ALPHA SERINE\/THREONINE-PROTEIN KINASE","Homo sapiens",4,"LEU A 202;SER A 205;ASP A 292;ASP A 274","LEU A 202 ( 0.6A);SER A 205 (-0.0A);ASP A 292 (-0.6A);ASP A 274 ( 0.5A)","1.34A","4qtuD-3o96A:undetectable","4qtuD-3o96A:18.68"],["4ZDZ_A_TPFA602_1","LANOSTEROL 14-ALPHA DEMETHYLASE","3o96","RAC-ALPHA SERINE\/THREONINE-PROTEIN KINASE","Homo sapiens",4,"PHE A 408;ILE A 402;GLY A 254;MET A 343","PHE A 408 ( 1.3A);ILE A 402 ( 0.4A);GLY A 254 ( 0.0A);MET A 343 ( 0.0A)","0.93A","4zdzA-3o96A:undetectable","4zdzA-3o96A:21.45"],["5ESJ_A_TPFA602_1","LANOSTEROL 14-ALPHA DEMETHYLASE","3o96","RAC-ALPHA SERINE\/THREONINE-PROTEIN KINASE","Homo sapiens",4,"PHE A 408;ILE A 402;GLY A 254;MET A 343","PHE A 408 ( 1.3A);ILE A 402 ( 0.4A);GLY A 254 ( 0.0A);MET A 343 ( 0.0A)","0.92A","5esjA-3o96A:undetectable","5esjA-3o96A:21.62"],["5IZF_E_AZ1E2_1","CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA;6J9-ZEU-DAR-ACA-DAR-NH2","3o96","RAC-ALPHA SERINE\/THREONINE-PROTEIN KINASE","Homo sapiens",4,"GLY A 157;GLY A 159;LYS A 179;LEU A 181","GLY A 157 ( 0.0A);GLY A 159 ( 0.0A);LYS A 179 ( 0.0A);LEU A 181 ( 0.6A)","0.18A","5izfA-3o96A:29.3","5izfA-3o96A:34.20"],["5IZJ_F_AZ1F2_1","CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA;47P-AZ1-DAR-DAR-DAR","3o96","RAC-ALPHA SERINE\/THREONINE-PROTEIN KINASE","Homo sapiens",5,"GLY A 157;GLY A 159;GLY A 162;VAL A 164;LEU A 181","GLY A 157 ( 0.0A);GLY A 159 ( 0.0A);GLY A 162 ( 0.0A);VAL A 164 ( 0.6A);LEU A 181 ( 0.6A)","0.19A","5izjB-3o96A:30.4","5izjB-3o96A:34.20"],["5IZJ_G_AZ1G2_1","CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA;47P-AZ1-DAR-DAR","3o96","RAC-ALPHA SERINE\/THREONINE-PROTEIN KINASE","Homo sapiens",5,"GLY A 157;GLY A 159;VAL A 164;LYS A 179;LEU A 181","GLY A 157 ( 0.0A);GLY A 159 ( 0.0A);VAL A 164 ( 0.6A);LYS A 179 ( 0.0A);LEU A 181 ( 0.6A)","0.38A","5izjA-3o96A:30.3","5izjA-3o96A:34.20"],["5J5X_B_AZ1B2_1","CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA;47P-AZ1-DAL-DAR-DAR-DAR-DAR","3o96","RAC-ALPHA SERINE\/THREONINE-PROTEIN KINASE","Homo sapiens",4,"GLY A 157;GLY A 159;VAL A 164;LYS A 179","GLY A 157 ( 0.0A);GLY A 159 ( 0.0A);VAL A 164 ( 0.6A);LYS A 179 ( 0.0A)","0.41A","5j5xA-3o96A:29.5","5j5xA-3o96A:34.20"],["5MZJ_A_TEPA2401_1","ADENOSINE RECEPTOR A2A,SOLUBLE CYTOCHROME B562,ADENOSINE RECEPTOR A2A","3o96","RAC-ALPHA SERINE\/THREONINE-PROTEIN KINASE","Homo sapiens",4,"LEU A 335;GLU A 256;LEU A 280;ILE A 290","LEU A 335 ( 0.6A);GLU A 256 ( 0.6A);LEU A 280 ( 0.6A);ILE A 290 (-0.7A)","0.99A","5mzjA-3o96A:2.3","5mzjA-3o96A:20.28"],["5UUN_A_ACTA309_0","GLUTATHIONE S-TRANSFERASE-LIKE PROTEIN","3o96","RAC-ALPHA SERINE\/THREONINE-PROTEIN KINASE","Homo sapiens",4,"LEU A 392;GLY A 382;SER A 381;SER A 378","LEU A 392 ( 0.6A);GLY A 382 ( 0.0A);SER A 381 ( 0.0A);SER A 378 ( 0.0A)","1.28A","5uunA-3o96A:undetectable","5uunA-3o96A:20.90"]]